Laura Evans is a highly skilled scientist specializing in molecular oncology, with vast experience in target identification and development. Currently serving as an Associate Principal Scientist at Bayer since 2024, they previously worked as a Research Scientist in Oncology at Bayer Pharmaceuticals from 2020 to 2024. Laura completed a PhD at the Newcastle Cancer Centre from 2010 to 2014, where they identified SKP2 as a MYCN target gene and collaborated with structural biologists on novel small molecule synthesis. They also held a postdoctoral fellowship at the Dana-Farber Cancer Institute from 2015 to 2020. Laura earned a 2.1 degree in Biochemistry and Biological Chemistry from the University of Nottingham and a distinction in MRes in Biomedical and Biological Science from Newcastle University.
Location
Boston, United States
This person is not in the org chart
This person is not in any offices